CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 15, 2024 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 38,799 | -- | 184,271 |
| Feb 15, 2024 |
Director, President & CEO
Trans History: 126
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 84,270 | -- | 803,704 |
| Feb 15, 2024 |
Chief Innovation Officer
Trans History: 50
|
Chief Innovation Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 37,921 | -- | 246,228 |
| Feb 15, 2024 |
Chief Operating Officer
Trans History: 24
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 37,921 | -- | 215,616 |
| Feb 16, 2024 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 96,328 |
| Feb 16, 2024 |
Director
Trans History: 27
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 161,908 |
| Feb 16, 2024 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 80,671 |
| Feb 16, 2024 |
Director
Trans History: 57
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 93,506 |
| Feb 16, 2024 |
Director
Trans History: 22
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 111,936 |
| Feb 16, 2024 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 46,925 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.